Humedix Future Growth
Future criteria checks 4/6
Humedix is forecast to grow earnings and revenue by 24.9% and 14% per annum respectively. EPS is expected to grow by 24.3% per annum. Return on equity is forecast to be 20.2% in 3 years.
Key information
24.9%
Earnings growth rate
24.3%
EPS growth rate
Pharmaceuticals earnings growth | 32.8% |
Revenue growth rate | 14.0% |
Future return on equity | 20.2% |
Analyst coverage | Low |
Last updated | 03 Oct 2024 |
Recent future growth updates
Recent updates
Humedix (KOSDAQ:200670) Has A Pretty Healthy Balance Sheet
Mar 09Humedix Co., Ltd.'s (KOSDAQ:200670) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Feb 16Should You Buy Humedix Co., Ltd. (KOSDAQ:200670) For Its Dividend?
Jan 28Are Humedix's (KOSDAQ:200670) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 11What Type Of Returns Would Humedix's(KOSDAQ:200670) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Dec 22Here's Why Humedix (KOSDAQ:200670) Can Manage Its Debt Responsibly
Dec 01Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 238,000 | 53,333 | 50,333 | 69,667 | 3 |
12/31/2025 | 208,050 | 46,600 | 46,100 | 58,600 | 4 |
12/31/2024 | 182,400 | 43,950 | 37,100 | 46,650 | 4 |
12/31/2023 | 154,000 | 29,300 | 32,000 | 34,000 | 1 |
12/31/2021 | 110,992 | 9,065 | 4,441 | 19,185 | N/A |
9/30/2021 | 115,572 | 15,040 | 14,225 | 26,946 | N/A |
6/30/2021 | 111,600 | 15,988 | 17,401 | 28,724 | N/A |
3/31/2021 | 107,724 | 17,204 | 10,436 | 24,961 | N/A |
12/31/2020 | 98,481 | 15,084 | 6,070 | 23,762 | N/A |
9/30/2020 | 85,721 | 11,348 | -3,199 | 14,176 | N/A |
6/30/2020 | 84,844 | 10,717 | -1,450 | 14,820 | N/A |
3/31/2020 | 80,968 | 9,023 | 2,611 | 12,695 | N/A |
12/31/2019 | 78,619 | 10,420 | 4,469 | 13,810 | N/A |
9/30/2019 | 73,501 | 9,673 | 4,699 | 19,280 | N/A |
6/30/2019 | 68,859 | 9,888 | -1,529 | 18,138 | N/A |
3/31/2019 | 67,351 | 9,556 | 7,981 | 26,417 | N/A |
12/31/2018 | 64,832 | 9,208 | 7,034 | 23,803 | N/A |
9/30/2018 | 62,017 | 9,185 | 6,171 | 17,454 | N/A |
6/30/2018 | 58,670 | 9,610 | 5,984 | 14,378 | N/A |
3/31/2018 | 56,401 | 11,719 | -5,592 | 11,764 | N/A |
12/31/2017 | 54,727 | 11,940 | -10,732 | 8,765 | N/A |
9/30/2017 | 54,391 | 11,385 | -20,944 | 3,183 | N/A |
6/30/2017 | 51,753 | 10,332 | -17,285 | 8,250 | N/A |
3/31/2017 | 49,051 | 9,449 | -17,939 | 1,896 | N/A |
12/31/2016 | 47,134 | 10,275 | -14,789 | 7,609 | N/A |
12/31/2015 | 42,133 | 11,623 | 871 | 11,706 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A200670's forecast earnings growth (24.9% per year) is above the savings rate (2.7%).
Earnings vs Market: A200670's earnings (24.9% per year) are forecast to grow slower than the KR market (28.5% per year).
High Growth Earnings: A200670's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: A200670's revenue (14% per year) is forecast to grow faster than the KR market (9.5% per year).
High Growth Revenue: A200670's revenue (14% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A200670's Return on Equity is forecast to be high in 3 years time (20.2%)